The use of disease-modifying agents in multiple sclerosis--by the Canadian Network of MS Clinics.
O'Connor
Paul
P
Department of Neurology, St. Michael's Hospital (POC), Toronto, ON, Canada.
Devonshire
Virginia
V
D002170:Canada; D003195:Computer Communication Networks / Q000706:statistics & numerical data; D017408:Guidelines as Topic / Q000592:standards*; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D009103:Multiple Sclerosis / Q000188:drug therapy* / Q000453:epidemiology
D007155:Immunologic Factors; D007166:Immunosuppressive Agents